Who are Bio-Path Holdings, Inc.'s main suppliers?

Bio-Path Holdings, Inc. (BPTH) key suppliers include: STEEL-GIANTS-ADVISORS-LLC, Curis, Inc., Altamira Therapeutics Ltd.. View the full supplier network at chainsifter.com/chain/BPTH.

Who are Bio-Path Holdings, Inc.'s major customers?

Bio-Path Holdings, Inc. (BPTH) key customers include: Altamira Therapeutics Ltd., NASDAQ-STOCK-MARKET-LLC. View the full customer network at chainsifter.com/chain/BPTH.

What sector is Bio-Path Holdings, Inc. in?

Bio-Path Holdings, Inc. (BPTH) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Bio-Path Holdings, Inc. Suppliers, Customers & Supply Chain (BPTH)

3Suppliers

2Customers

3Debt Items

16Related Chains

Source-Backed Evidence Depth

Bio-Path Holdings, Inc. (BPTH) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

9Total relationships

2Distinct source URLs

5High confidence

0.811Average confidence

2026-10-28Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Bio-Path Holdings, Inc. Suppliers

Ticker	Name	Confidence	Evidence
STEEL-GIANTS-ADVISORS-LLC	STEEL-GIANTS-ADVISORS-LLC	92%	On October 24, 2025, the Company engaged Steel Giants Advisors LLC (“SGA”) to advise it
CRIS	Curis, Inc.	72%	Reciprocal relationship from CRIS graph: Reciprocal relationship from BPTH graph: Reciprocal relationship from CRIS graph: Reciprocal relationship from BPTH graph: Reciprocal relationship from CRIS g…
CYTOF	Altamira Therapeutics Ltd.	72%	Reciprocal relationship from CYTOF graph: Reciprocal relationship from BPTH graph: Reciprocal relationship from CYTOF graph: Reciprocal relationship from BPTH graph: Reciprocal relationship from CYTO…

Bio-Path Holdings, Inc. Customers

Ticker	Name	Confidence	Evidence
CYTOF	Altamira Therapeutics Ltd.	72%	Reciprocal relationship from CYTOF graph: Reciprocal relationship from BPTH graph: Reciprocal relationship from CYTOF graph: Reciprocal relationship from BPTH graph: Reciprocal relationship from CYTO…
NASDAQ-STOCK-MARKET-LLC	NASDAQ-STOCK-MARKET-LLC	62%	mmon stock up to a whole share of common stock. All common stock share and per share amounts in this Quarterly Report on Form 10-Q have been adjusted to give effect to the 1-for-20 reverse stock spli…

Bio-Path Holdings, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
BPTH-DEBT	Debt stack $511,000	90%	Market cache reports total debt of $511,000.
BPTH-DEBT-8347	Warrants outstanding: 44625	90%	xbrl warrant detail from xbrl 2024-12-31.
BPTH-DEBT-8348	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2025-09-30.

Bio-Path Holdings, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Bio-Path Holdings, Inc..

Bio-Path Holdings, Inc. Ownership

Holder	Name	Confidence	Evidence
BPTH-OWNER-DANSKE-BANK-A-S	DANSKE BANK A/S	90%	13F overlay lists DANSKE BANK A/S as top holder; 1 tracked holders.

Bio-Path Holdings, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
RIGL	Rigel Pharmaceuticals, Inc.	100.00	2
JNJ	Johnson & Johnson	100.00	2
LLY	Eli Lilly and Company	100.00	2
STTK	Shattuck Labs, Inc.	100.00	2
CRIS	Curis, Inc.	100.00	1	['supplier']
GILD	Gilead Sciences, Inc.	100.00	2
NRIX	Nurix Therapeutics, Inc.	100.00	2
SNYNF	Sanofi	100.00	2
CYTOF	Altamira Therapeutics Ltd.	100.00	1	['customer', 'supplier']
RNAZ	TransCode Therapeutics, Inc.	100.00	2
VINC	Vincerx Pharma, Inc.	100.00	2
ALKS	Alkermes plc	50.00	2
HTGC	Hercules Capital, Inc.	50.00	2
ORANY	ORANGE	50.00	2
RNAM	Avidity Biosciences, Inc.	50.00	2
ROCHE	ROCHE	23.09	2

Bio-Path Holdings, Inc. Supply Chain